Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Supplemental
Segments

Unit Economics
Common Size IS
Op Efficiency
Credit Analysis

LIGAND PHARMACEUTICALS INC (LGND)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18Dec-31-17Dec-05-17
   8-K10-K10-K10-K10-K8-K10-K8-K
Total revenues   [+]196.2277.1186.4120.3251.5251.5141.188.7
            Revenue growth  -29.2%48.7%55.0%-52.2%78.2%183.5%29.5% 
Cost of goods sold  123.147.223.416.915.850.012.144.4
Gross profit  73.1230.0163.0103.4235.7201.5129.044.3
            Gross margin  37.2%83.0%87.4%86.0%93.7%80.1%91.4%50.0%
Selling, general and administrative   [+]70.157.564.441.937.737.728.728.7
Research and development   69.059.455.927.9 26.9 
Equity in earnings          
EBITDA   [+] 130.051.5825.4176.5 79.0 
            EBITDA margin  1.5%46.9%27.6%686.3%70.2%65.1%56.0%76.8%
Depreciation   3.92.31.5-3.0 -1.1 
EBITA  3.0126.149.2824.0179.5163.780.268.1
            EBITA margin  1.5%45.5%26.4%685.0%71.4%65.1%56.8%76.8%
Amortization of intangibles   47.223.416.915.8 12.1 
EBIT   [+]3.078.925.8807.1163.7163.768.168.1
            EBIT margin  1.5%28.5%13.9%671.0%65.1%65.1%48.2%76.8%
Interest expense, net   [+]-0.218.719.37.334.3 11.411.4
Other income (expense), net   [+]32.7-12.9-17.0-3.143.99.60.60.6
Pre-tax income  36.047.3-10.5796.6173.3173.357.257.2
Income taxes  41.2-9.8-7.6167.330.00.044.7-44.7
            Tax rate  114.5% 71.7%21.0%17.3%0.0%78.1% 
Earnings from continuing ops  -5.257.1-3.0629.3143.3 12.6 
Earnings from discontinued ops  -28.1       
Net income  -33.457.1-3.0629.3143.30.012.60.0
            Net margin  -17.0%20.6%-1.6%523.2%57.0%0.0%8.9%0.0%
   
Basic EPS   [+]($0.31)$3.44($0.18)$33.13$6.77 $0.60 
Diluted EPS   [+]($0.31)$3.31($0.18)$31.85$5.96 $0.53 
   
Shares outstanding (basic)   [+]16.816.616.219.021.2 21.0 
Shares outstanding (diluted)   [+]16.817.216.219.824.1 23.5 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy